Zardaverine
- Level
- Commodity
- Parent
- 51161500
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51161557This classification denotes a phosphodiesterase inhibitor and bronchodilator, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier TQ358GWH6Y. European Medicines Agency schedules Zardaverine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00142MIG. Zardaverine generally arises in the molecular formula C12H10F2N2O3. The term ZARDAVERINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, no. 3, 1989, list 29.) ZARDAVERINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule zardaverine under HS 29339990 and SITC 51577. As of Q4 2014, ZARDAVERINE remains the US FDA Preferred Term for this commodity. Zardaverine bears US NLM identifiers UMLS ID C0085049 and NCI Concept Code C66686. SMILES: COC1=C(C=CC(=C1)C2=NNC(=O)C=C2)OC(F)F.
Same parent
Under 51161500 · 56Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.